Thrivent Financial for Lutherans’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.18M | Sell |
|
|||||
|
2025
Q2 | $1.06M | Sell |
|
|||||
|
2025
Q1 | $1.1M | Sell |
|
|||||
|
2024
Q4 | $1.49M | Buy |
|
|||||
|
2024
Q3 | $1.5M | Buy |
|
|||||
|
2024
Q2 | $225K | Sell |
|
|||||
|
2024
Q1 | $1.23M | Sell |
|
|||||
|
2023
Q4 | $1.15M | Sell |
|
|||||
|
2023
Q3 | $1.37M | Sell |
|
|||||
|
2023
Q2 | $4.39M | Buy |
|
|||||
|
2023
Q1 | $1.81M | Buy |
|
|||||
|
2022
Q4 | $1.59M | Sell |
|
|||||
|
2022
Q3 | $3.14M | Sell |
|
|||||
|
2022
Q2 | $3.73M | Sell |
|
|||||
|
2022
Q1 | $5.2M | Buy |
|
|||||
|
2021
Q4 | $4.08M | Sell |
|
|||||
|
2021
Q3 | $4.34M | Sell |
|
|||||
|
2021
Q2 | $3.77M | Buy |
|
|||||
|
2021
Q1 | $3.34M | Sell |
|
|||||
|
2020
Q4 | $3.78M | Sell |
|
|||||
|
2020
Q3 | $10.1M | Buy |
|
|||||
|
2020
Q2 | $7.63M | Sell |
|
|||||
|
2020
Q1 | $14.1M | Sell |
|
|||||
|
2019
Q4 | $25.5M | Buy |
|
|||||
|
2019
Q3 | $7.32M | Buy |
|
|||||
|
2019
Q2 | $3.9M | Buy |
|
|||||
|
2019
Q1 | $3.79M | Buy |
|
|||||
|
2018
Q4 | $1.18M | Buy |
|
|||||
|
2018
Q3 | $1.52M | Buy |
|
|||||
|
2018
Q2 | $1.33M | Buy |
|
|||||
|
2018
Q1 | $1.15M | Buy |
|
|||||
|
2017
Q4 | $1.05M | Buy |
|
|||||
|
2017
Q3 | $949K | Buy |
|
|||||
|
2017
Q2 | $950K | Buy |
|
|||||
|
2017
Q1 | $779K | Buy |
|
|||||
|
2016
Q4 | $649K | Buy |
|
|||||
|
2016
Q3 | $532K | Sell |
|
|||||
|
2016
Q2 | $1.95M | Buy |
|
|||||
|
2016
Q1 | $1.82M | Buy |
|
|||||
|
2015
Q4 | $1.81M | Buy |
|
|||||
|
2015
Q3 | $309K | Buy |
|
|||||
|
2015
Q2 | $316K | Buy |
|
|||||
|
2015
Q1 | $216K | Buy |
|